Strikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage

2012/05/17 by Katherine R. Smith, Katherine R. Smith, John A. Damiano +22 · 30 citations
Medicine · Biochemistry, Genetics and Molecular Biology · Neuroscience · #Amyotrophic Lateral Sclerosis Research #Genomics and Rare Diseases #Genetic Neurodegenerative Diseases

paper · pdf · doi:10.1016/j.ajhg.2012.04.021

Abstract

We performed hypothesis-free linkage analysis and exome sequencing in a family with two siblings who had neuronal ceroid lipofuscinosis (NCL). Two linkage peaks with maximum LOD scores of 3.07 and 2.97 were found on chromosomes 7 and 17, respectively. Unexpectedly, we found these siblings to be homozygous for a c.813₈16del (p.Thr272Serfs∗10) mutation in the progranulin gene (GRN, granulin precursor) in the latter peak. Heterozygous mutations in GRN are a major cause of frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP), the second most common early-onset dementia. Reexamination of progranulin-deficient mice revealed rectilinear profiles typical of NCL. The age-at-onset and neuropathology of FTLD-TDP and NCL are markedly different. Our findings reveal an unanticipated link between a rare and a common neurological disorder and illustrate pleiotropic effects of a mutation in the heterozygous or homozygous states.

Cited by

• The lysosomal function of progranulin, a guardian against neurodegeneration
• Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis
• LRP10 promotes trafficking of progranulin and prosaposin to lysosomes
• Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
• Dissociation of frontotemporal dementia-related deficits and neuroinflammation in progranulin haploinsufficient mice. [europepmc]
• NCL diseases - clinical perspectives. [europepmc]
• Alzheimer's disease genetics: from the bench to the clinic. [europepmc]
• Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice. [europepmc]
• Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. [europepmc]
• Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models. [europepmc]
• Genetics of the neuronal ceroid lipofuscinoses (Batten disease). [europepmc]
• Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. [europepmc]
• Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. [europepmc]
• The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway. [europepmc]
• ER stress and impaired autophagy flux in neuronal degeneration and brain injury. [europepmc]
• Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. [europepmc]
• Frontotemporal Dementia. [europepmc]
• Progranulin, lysosomal regulation and neurodegenerative disease. [europepmc]
• Loss of TMEM106B Ameliorates Lysosomal and Frontotemporal Dementia-Related Phenotypes in Progranulin-Deficient Mice. [europepmc]
• Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis. [europepmc]
• The lysosomal function of progranulin, a guardian against neurodegeneration. [europepmc]
• An Overview of the Role of Lipofuscin in Age-Related Neurodegeneration. [europepmc]
• Therapeutic landscape for Batten disease: current treatments and future prospects. [europepmc]
• Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies. [europepmc]
• Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer's Disease Genetics. [europepmc]
• Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis. [europepmc]
• Rescue of a lysosomal storage disorder caused by Grn loss of function with a brain penetrant progranulin biologic. [europepmc]
• Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. [europepmc]
• Rare variant associations with plasma protein levels in the UK Biobank. [europepmc]

Related

• Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration
• Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP‐43 inclusions and ageing‐related tau astrogliopathy in a family with a GBE1 mutation
• The genetic landscape of frontotemporal lobar degeneration: investigation of a diagnostic cohort of 2747 probands
• Transplantation of Human IPSC-derived Microglia Ameliorates Neuropathology and Circuit Dysfunction in Progranulin-Deficient Mice
• Distinguishing post‐translational modifications in dominantly inherited frontotemporal dementias: FTLD‐TDP Type A ( <i>GRN</i> ) vs Type B ( <i>C9orf72</i> )